SCHEMBL4619624

SCHEMBL4619624

COc1cc(Br)c(CCNS(=O)(=O)c2cc(S(=O)(=O)c3ccc(Cl)cc3)ccc2C)cc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 2/20 0.52
ALDH1A1 P00352 5/20 0.47
HPGD P15428 3/20 0.47
POLB P06746 2/20 0.47
USP2 O75604 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
LMNA P02545 3/20 0.47
HTT P42858 1/20 0.47
MAPT P10636 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.42
HTR2A P28223 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4616172 0.92 SFRP1 (0.54) SFRP1ALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL4617894 0.91 SFRP1 (0.64) SFRP1ALDH1A1HPGDPOLBCYP1A2
SCHEMBL6104080 0.90 ALDH1A1 (0.52) SFRP1ALDH1A1HPGDUSP2TSHR
SCHEMBL4619239 0.87 SFRP1 (0.51) SFRP1ALDH1A1HPGDPOLBUSP2
SCHEMBL4619170 0.86 SFRP1 (0.59) SFRP1ALDH1A1HPGDPOLBUSP2
SCHEMBL4616896 0.84 SFRP1 (0.52) SFRP1ALDH1A1HPGDPOLBUSP2
SCHEMBL6101030 0.84 SFRP1 (0.66) SFRP1ALDH1A1POLBSMN1; SMN2LMNA
SCHEMBL6102921 0.80 SFRP1 (0.59) SFRP1ALDH1A1HPGDPOLBTSHR
SCHEMBL4618199 0.80 SFRP1 (0.60) SFRP1ALDH1A1POLBSMN1; SMN2LMNA
SCHEMBL6103295 0.79 SFRP1 (0.75) SFRP1ALDH1A1HPGDPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885ALDH1A1 1865/4885HPGD 2925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.